Vesalius Longevity Labs Appoints Dr. Deepti Agarwal to Scientific Advisory Board
FORIMMEDIATE RELEASE
Vesalius Longevity Labs Appoints Dr. Deepti Agarwal to Scientific Advisory Board
SCOTTSDALE,Ariz. — Aug. 14, 2025 — Vesalius LongevityLabs has announced the appointment of Dr. Deepti Agarwal to its ScientificAdvisory Board, bringing extensive expertise in integrative pain management,regenerative medicine and wellness to the company’s growing network ofscientific leaders.
Aboard-certified anesthesiologist, pain management specialist and integrativemedicine physician, Dr. Agarwal has an exceptional track record of advancinginnovative treatment protocols. Her clinical and research experience spansinterventional pain therapies, non-opioid pain management, regenerativetechniques and comprehensive wellness strategies. She has served in leadershiproles across hospital systems, private practice and academic medicine, and isrecognized for her patient-centered approach to improving quality of life.
“With her uniquecombination of clinical expertise and visionary thinking, Dr. Agarwal will beinvaluable as we advance our mission to provide premium peptides built onquality, transparency and trust,” said Dr. Pradeep Albert, chief medicalofficer of Vesalius Longevity Labs. “Her work at the intersection of science,wellness and regenerative medicine makes her a perfect fit for our Scientific AdvisoryBoard.”
Dr. Agarwal addsthat she looks forward to collaborating with the Vesalius team. “VesaliusLongevity Labs is transforming the peptide landscape,” she shares. “I’m excitedto join this prestigious board of experts to translate emerging science intoimpactful, real-world solutions and contribute to a mission that aligns soclosely with my passions.”
AboutVesalius Longevity Labs
Vesalius Longevity Labs, a next-generation health solutions company, is leading a new frontier of health andwellness. Guided by clinical researchers, MDs, and biotech veterans, Vesaliusis harnessing the power of peptides to deliver advanced health productsand services grounded in state-of-the-art science. Distributed through a global, end-to-end B2Doctor ecosystem,fulfillment and compliance service, Vesalius’s comprehensive product portfolioincludes injectables, patches, nasal sprays, oral peptides and topical formulations.
Media Contact:
Vesalius Longevity Labs
Email: info@vesaliuslabs.com
www.vesaliuslabs.com